James N Topper's Net Worth

$721 Million

Estimate Recalculated Feb 27, 2024 09:33PM EST

Who is James N Topper?

James N Topper has an estimated net worth of $721 Million. This is based on reported shares across multiple companies, which include GLAUKOS Corp, Tarsus Pharmaceuticals, Inc., ALPINE IMMUNE SCIENCES, INC., COLLEGIUM PHARMACEUTICAL, INC, Phathom Pharmaceuticals, Inc., ANAPTYSBIO, INC, Sierra Oncology, Inc., Mirum Pharmaceuticals, Inc., AMICUS THERAPEUTICS INC, Frazier Lifesciences Acquisition Corp, Allena Pharmaceuticals, Inc., Entasis Therapeutics Holdings Inc., Passage BIO, Inc., Arcutis Biotherapeutics, Inc., LA JOLLA PHARMACEUTICAL CO, Aptinyx Inc., HilleVax, Inc., and PORTOLA PHARMACEUTICALS INC.

SEC CIK

James N Topper's CIK is 0001341382

Past Insider Trading and Trends

2008 was James N Topper's most active year for acquiring shares with 802 total transactions. James N Topper's most active month to acquire stocks was the month of January. 2020 was James N Topper's most active year for disposing of shares, totalling 13 transactions. James N Topper's most active month to dispose stocks was the month of May. 2022 saw James N Topper paying a total of $73,012,773.50 for 4,902,805 shares, this is the most they've acquired in one year. In 2020 James N Topper cashed out on 18,521,235 shares for a total of $250,010.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GLAUKOS Corp (GKOS) Snapshot price: $94.635

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.6M
2.6M
Jun 30
Form 4
0
0
Jun 26
Form 3
0
0
No matching records found

COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.26

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.89M
$12.00
1.89M
May 12
Form 3
0
0
No matching records found

Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $29.805

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.92M
$16.00
1.92M
Oct 20
Form 3
0
0
No matching records found

ALPINE IMMUNE SCIENCES, INC. (ALPN) Snapshot price: $27.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 2
Form 4
+9.79%
145.25K
$12.74
$1,850,497.74
1.63M
Dec 11
Form 4
0
0
Jan 3
Form 4
+8.22%
112.67K
$7.10
$799,989.10
1.48M
Feb 11
Form 4
0
0
Jan 3
Form 4
-46.67%
-1.20M
1.37M
Sep 17
Form 4
0
0
Jan 4
Form 4
0
0
Jan 2
Form 4
+16.94%
372.44K
$5.37
$1,999,997.43
2.57M
Jan 18
Form 4
0
0
Jan 2
Form 4
0
0
Jan 2
Form 4
2.2M
2.2M
Jul 24
Form 3
0
0
No matching records found

Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+71.45%
9K
21.6K
May 25
Form 4
0
0
Sep 22
Form 4
-20.00%
-1.46M
5.83M
Jun 12
Form 4
0
0
May 21
Form 4
+49.33%
2.41M
$16.86
$40,575,317.00
7.28M
Oct 29
Form 3
0
0
No matching records found